%PDF-1.4
%
210 0 obj
<>
endobj
212 0 obj
<>stream
2016-03-18T11:01:32-05:00
2016-05-27T04:39-07:00
2016-05-27T04:39-07:00
itext-paulo-155 (itextpdf.sf.net-lowagie.com)
application/pdf
Preclinical Evaluation of Fatty Acid Synthase and EGFR Inhibition in Triple Negative Breast Cancer
uuid:9c896bb9-1dd1-11b2-0a00-9d08279d8f00
uuid:9c896bbc-1dd1-11b2-0a00-b30000000000
endstream
endobj
204 0 obj
<>
endobj
1 0 obj
<>
endobj
213 0 obj
<>
endobj
214 0 obj
<>
endobj
215 0 obj
<>
endobj
12 0 obj
<>/Font<>/ProcSet[/PDF/Text]>>/Rotate 0/Type/Page>>
endobj
13 0 obj
<>/Font<>/ProcSet[/PDF/Text]>>/Rotate 0/Type/Page>>
endobj
14 0 obj
<>/Font<>/ProcSet[/PDF/Text]>>/Rotate 0/Type/Page>>
endobj
15 0 obj
<>/Font<>/ProcSet[/PDF/Text]>>/Rotate 0/Type/Page>>
endobj
16 0 obj
<>/Font<>/ProcSet[/PDF/Text]>>/Rotate 0/Type/Page>>
endobj
17 0 obj
<>/Font<>/ProcSet[/PDF/Text]>>/Rotate 0/Type/Page>>
endobj
18 0 obj
<>/Font<>/ProcSet[/PDF/Text]>>/Rotate 0/Type/Page>>
endobj
19 0 obj
<>/Font<>/ProcSet[/PDF/Text]>>/Rotate 0/Type/Page>>
endobj
20 0 obj
<>/Font<>/ProcSet[/PDF/Text]>>/Rotate 0/Type/Page>>
endobj
21 0 obj
<>/Font<>/ProcSet[/PDF/Text]>>/Rotate 0/Type/Page>>
endobj
22 0 obj
<>/Font<>/ProcSet[/PDF/Text]>>/Rotate 0/Type/Page>>
endobj
23 0 obj
<>/Font<>/ProcSet[/PDF/Text]>>/Rotate 0/Type/Page>>
endobj
24 0 obj
<>/Font<>/ProcSet[/PDF/Text]>>/Rotate 0/Type/Page>>
endobj
25 0 obj
<>/Font<>/ProcSet[/PDF/Text]>>/Rotate 0/Type/Page>>
endobj
26 0 obj
<>/Font<>/ProcSet[/PDF/Text]>>/Rotate 0/Type/Page>>
endobj
27 0 obj
<>/Font<>/ProcSet[/PDF/Text]>>/Rotate 0/Type/Page>>
endobj
28 0 obj
<>/ExtGState<>/Font<>/ProcSet[/PDF/Text]>>/Rotate 0/Type/Page>>
endobj
29 0 obj
<>/MediaBox[0 0 396.9 518.88]/Parent 215 0 R/Resources<>/Font<>/ProcSet[/PDF/Text/ImageC]/XObject<>>>/StructParents 0/Tabs/S/Type/Page>>
endobj
30 0 obj
<>/MediaBox[0 0 496.14 648.12]/Parent 215 0 R/Resources<>/Font<>/ProcSet[/PDF/Text/ImageC]/XObject<>>>/StructParents 0/Tabs/S/Type/Page>>
endobj
31 0 obj
<>/MediaBox[0 0 425.28 540]/Parent 215 0 R/Resources<>/Font<>/ProcSet[/PDF/Text/ImageC]/XObject<>>>/StructParents 0/Tabs/S/Type/Page>>
endobj
32 0 obj
<>/MediaBox[0 0 510.24 425.28]/Parent 215 0 R/Resources<>/Font<>/ProcSet[/PDF/Text/ImageC]/XObject<>>>/StructParents 0/Tabs/S/Type/Page>>
endobj
216 0 obj
<>/ProcSet[/PDF/Text/ImageC]/XObject<>>>/Type/Page>>
endobj
278 0 obj
[284 0 R 285 0 R 286 0 R 287 0 R 288 0 R 289 0 R]
endobj
279 0 obj
<>stream
q
539.3594055 0 0 83.3014526 36.3202972 660.6985474 cm
/Im0 Do
Q
BT
/T1_0 1 Tf
10 0 0 10 105.56995 562.99985 Tm
( Published OnlineFirst April 22, 2016.)Tj
/T1_1 1 Tf
-7.55699 0 Td
(Clin Cancer Res\240)Tj
/T1_0 1 Tf
0 1 TD
(\240 )Tj
0 1.00001 TD
(Ariadna Gir\363-Perafita, Sonia Palomeras, David Lum, et al. )Tj
/T1_2 1 Tf
0 1 TD
(\240 )Tj
/T1_3 1 Tf
18 0 0 18 30 602.99997 Tm
(Inhibition in Triple Negative Breast Cancer)Tj
T*
(Preclinical Evaluation of Fatty Acid Synthase and EGFR)Tj
ET
30 442 552 101 re
0 0 m
S
BT
/T1_0 1 Tf
11 0 0 11 120.94202 515.99997 Tm
(\240 )Tj
/T1_3 1 Tf
-7.55696 1 Td
(Updated version)Tj
ET
BT
/T1_2 1 Tf
10 0 0 10 141 507.99994 Tm
(\240 )Tj
/T1_0 1 Tf
16.73097 1 Td
( )Tj
0 0 1 rg
-15.11898 0 Td
(10.1158/1078-0432.CCR-15-3133)Tj
0 g
-1.61199 0 Td
(doi:)Tj
0 1.00001 TD
(Access the most recent version of this article at:)Tj
ET
BT
/T1_0 1 Tf
11 0 0 11 120.94202 474.99994 Tm
(\240 )Tj
/T1_3 1 Tf
-3.50099 1 Td
(Material)Tj
-3.44499 1.00001 Td
(Supplementary)Tj
ET
BT
/T1_2 1 Tf
10 0 0 10 141 477.99994 Tm
(\240 )Tj
/T1_0 1 Tf
43.29691 1 Td
( )Tj
0 0 1 rg
-43.29691 0 Td
(http://clincancerres.aacrjournals.org/content/suppl/2016/04/22/1078-0432\
.CCR-15-3133.DC1.html)Tj
0 g
T*
(Access the most recent supplemental material at:)Tj
ET
BT
/T1_0 1 Tf
11 0 0 11 120.94202 441.99994 Tm
(\240 )Tj
/T1_3 1 Tf
-5.05597 1 Td
(Manuscript)Tj
2.05699 1.00001 Td
(Author)Tj
ET
BT
/T1_0 1 Tf
10 0 0 10 141 454.99997 Tm
(edited. )Tj
0 1 TD
(Author manuscripts have been peer reviewed and accepted for publication \
but have not yet been)Tj
ET
BT
/T1_2 1 Tf
10 0 0 10 30 421.99997 Tm
(\240 )Tj
T*
(\240 )Tj
ET
BT
/T1_2 1 Tf
10 0 0 10 30 401.99997 Tm
(\240 )Tj
T*
(\240 )Tj
ET
BT
/T1_2 1 Tf
10 0 0 10 30 381.99997 Tm
(\240 )Tj
T*
(\240 )Tj
ET
30 287 552 95 re
0 0 m
S
BT
/T1_0 1 Tf
11 0 0 11 120.94202 349.99997 Tm
(\240 )Tj
/T1_3 1 Tf
-5.66901 1 Td
(E-mail alerts)Tj
ET
BT
/T1_0 1 Tf
10 0 0 10 295.4996 362 Tm
( related to this article or journal.)Tj
0 0 1 rg
-15.44996 0 Td
(Sign up to receive free email-alerts)Tj
ET
BT
0 g
/T1_0 1 Tf
11 0 0 11 120.94202 316.99994 Tm
(\240 )Tj
/T1_3 1 Tf
-6.38997 1 Td
(Subscriptions)Tj
0.556 1.00001 Td
(Reprints and )Tj
ET
BT
/T1_0 1 Tf
10 0 0 10 141 319.99994 Tm
(\240 )Tj
13.46496 1 Td
(.)Tj
0 0 1 rg
-6.85098 0 Td
(pubs@aacr.org)Tj
0 g
-6.61398 0 Td
(Department at)Tj
0 1.00001 TD
(To order reprints of this article or to subscribe to the journal, contac\
t the AACR Publications)Tj
ET
BT
/T1_0 1 Tf
11 0 0 11 120.94202 294.99997 Tm
(\240 )Tj
/T1_3 1 Tf
-5.66901 1 Td
(Permissions)Tj
ET
BT
/T1_0 1 Tf
10 0 0 10 141 286.99994 Tm
(\240 )Tj
16.63094 1 Td
(.)Tj
0 0 1 rg
-10.01696 0 Td
(permissions@aacr.org)Tj
0 g
-6.61398 0 Td
(Department at)Tj
T*
(To request permission to re-use all or part of this article, contact the\
AACR Publications)Tj
ET
BT
/T1_0 1 Tf
9 0 0 9 283.24257 1.99997 Tm
(Research. )Tj
0.24098 1 Td
(on May 27, 2016. \251 2016 American Association for Cancer)Tj
0 0 1 rg
-13.61496 0 Td
(clincancerres.aacrjournals.org )Tj
0 g
-8.11398 0 Td
(Downloaded from )Tj
ET
BT
/T1_0 1 Tf
9 0 0 9 96.63571 769.99997 Tm
(Author manuscripts have been peer reviewed and accepted for publication \
but have not yet been edited. )Tj
1.1695 1 Td
(Author Manuscript Published OnlineFirst on April 22, 2016; DOI: 10.1158/\
1078-0432.CCR-15-3133 )Tj
ET
endstream
endobj
283 0 obj
<>/Filter/FlateDecode/Height 238/Length 73913/Name/X/Subtype/Image/Type/XObject/Width 1541>>stream
HϏn`'G6R0"#AKH"9\C| \?9-5= w#b"`ͼJ13;uKUoOu{^E +CD. K @Dd GD. K @Dd GD. K @Dd GD. K @Dd GD. K @Dd GD. K @Dd GD. K @Dd GD. K @Dd i꺖lƽeYڽ=
!Y2u]QEIeUQ:h\yq]&;qjm#qb^նmUUI-Vmi݃s}
էIiԮ{[R&LڝX;
;A;lDzog^ ilf $L2쪇͓ؿy$N&oar@1i|X$ݾwN9߄ͷ11&ldD ǩ}ƏVovT:np9i_ABM2$)4G&ʲL^UMupzXz~k˶
U\:p+aw!s+sa,ڙvm۪M5fIYO|IuUl1-&(|>Y&J%n0n/2%Ǻlnag^84|sb4 />]TI~~km۪lh4wY#nI:7eY~-İV?ߴML66C-睔Mj\